Log In
BCIQ
Print this Print this
 

Omnaris, ciclesonide nasal spray

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionCorticosteroid aerosol nasal formulation using hydrofluoroalkane (HFA)
Molecular Target Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRhinitis
Indication DetailsTreat seasonal allergic rhinitis (SAR)
Regulatory Designation
PartnerSumitomo Dainippon Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$575.0M

$575.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/16/2015

$575.0M

$575.0M

0

Get a free BioCentury trial today